ARCHIVES

Mozobil Plus G-CSF Increases Rate Of Cell Mobilization

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

NCI RFP Available.

February 11, 2000

Nimer to Lead Miami Sylvester Cancer Center

March 9, 2012

Norton Succeeds Einhorn As ASCO President, Colorado’s Paul Bunn Is President-Elect.

May 11, 2001

DCCP Board Okays New, Recompeting Contracts Worth $4.6 Million In ‘81

October 17, 1980

U.S., Canada To Collaborate On Indian Health Services.

May 17, 2002